Reuters

Thomson Reuters Announces Annual Renewal of Normal Course Issuer Bid and New US$2.0 Billion Share Repurchase Program

Retrieved on: 
Wednesday, June 8, 2022

TORONTO, June 8, 2022 /PRNewswire/ -- Thomson Reuters Corporation (TSX/NYSE: TRI) today announced it has received approval from the Toronto Stock Exchange (TSX) for the annual renewal of its normal course issuer bid (NCIB).

Key Points: 
  • TORONTO, June 8, 2022 /PRNewswire/ -- Thomson Reuters Corporation (TSX/NYSE: TRI) today announced it has received approval from the Toronto Stock Exchange (TSX) for the annual renewal of its normal course issuer bid (NCIB).
  • The company also announced that it plans to repurchase up to US$2.0 billion of its shares under the new NCIB.
  • Thomson Reuters has historically maintained a disciplined capital strategy that balances growth, long-term financial leverage, credit ratings and returns to shareholders through dividends and share repurchases.
  • Except as may be required by applicable law, Thomson Reuters disclaims any obligation to update or revise any forward-looking statements.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Target Corporation (TGT) on Behalf of Investors

Retrieved on: 
Wednesday, June 8, 2022

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Target Corporation (Target or the Company) (NYSE: TGT ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Target Corporation (Target or the Company) (NYSE: TGT ) investors concerning the Companys possible violations of the federal securities laws.
  • On May 18, 2022, Target announced its first quarter 2022 financial results in a press release.
  • On this news, Targets stock fell $3.69, or 2.3%, to close at $155.98 per share on June 7, 2022, thereby injuring investors.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Energy Transfer LP (ET) on Behalf of Investors

Retrieved on: 
Wednesday, June 8, 2022

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Energy Transfer LP (Energy Transfer or the Company) (NYSE: ET ) investors concerning the Companys possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Energy Transfer LP (Energy Transfer or the Company) (NYSE: ET ) investors concerning the Companys possible violations of the federal securities laws.
  • On this news, Energy Transfers stock fell $0.65, or 4.6%, over two trading days to close at $13.38 per share on August 12, 2019, thereby injuring investors.
  • Whistleblower Notice: Persons with non-public information regarding Energy Transfer should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

Pharma Intelligence Appoints General Counsel, Chief Commercial Officer

Retrieved on: 
Wednesday, June 8, 2022

NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- In the wake of its acquisition by leading global growth investor Warburg Pincus, Pharma Intelligence announces the appointments of Vicky Harris as General Counsel and Jeff Huntsman as Chief Commercial Officer (CCO).

Key Points: 
  • NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- In the wake of its acquisition by leading global growth investor Warburg Pincus, Pharma Intelligence announces the appointments of Vicky Harris as General Counsel and Jeff Huntsman as Chief Commercial Officer (CCO).
  • Prior to joining Pharma Intelligence, Harris was the head of the legal department at Clarivate, where she helped establish the business as a standalone organization following its sale from Thomson Reuters.
  • Previously, Huntsman was the Chief Commercial Officer for Connective RX.
  • I am delighted that Vicky and Jeff are joining our Pharma Intelligence team, said Ramsey Hashem, CEO of Pharma Intelligence.

Responding to Crisis in Ukraine: Teleperformance, HOPE worldwide and Feed the Children Join Forces to Help the Hurting

Retrieved on: 
Tuesday, June 7, 2022

Knowing it takes all of us working together to help those who are hurting, Teleperformance, HOPE worldwide and Feed the Children have joined forces to distribute food to several key Ukrainian cities and refugee areas.

Key Points: 
  • Knowing it takes all of us working together to help those who are hurting, Teleperformance, HOPE worldwide and Feed the Children have joined forces to distribute food to several key Ukrainian cities and refugee areas.
  • "In these unprecedented times, it's more important than ever to inspire greater hope,'' said Dave Malutinok, president and CEO of HOPE worldwide.
  • "Feed the Children has been a long-time valued partner of Teleperformance, and we are proud to work with them and HOPE worldwide on this critical need."
  • For more than 40 years, Feed the Children has mobilized its resources and responded when children needed food.

New Helium 10 Report Analyzes Seasonality on Amazon, Predicts This Year's Christmas Shopping Season May Start As Early As July

Retrieved on: 
Tuesday, June 7, 2022

IRVINE, Calif., June 7, 2022 /PRNewswire/ -- Helium 10, the leading all-in-one software and analytics solution for e-commerce sellers, today releases 'Tis the Season: How to Prime Your Business on Amazon for Q4, a report that leverages Helium 10's robust data capabilities and analysis to provide ecommerce business owners with tactics to optimize their strategies and successfully leverage surging holiday search traffic on Amazon. The report findings examine search volume data, pay-per-click (PPC) trends, and keyword optimization strategies, resulting in a deeper understanding of seasonal purchase habits so sellers can make impactful business decisions during the fourth quarter of 2022 and beyond.

Key Points: 
  • "Data is a critical component for new and seasoned sellers alike to prepare for the holiday season shopping rush on Amazon and emerge successful.
  • Annual forecasts for 2022 from The National Retail Federation and Reuters both predict YoY growth for retail and online sales.
  • Helium 10's analysis indicates consumer spending is expected to be high for Halloween this year and the weeks following Black Friday.
  • Download the full report here to read about the seasonal trends observed on Amazon and learn about Helium 10's recommendations for sellers.

mCloud Announces First Upstream Digital Oilfield Solutions in the United States, Launches New Connected Worker Online Store

Retrieved on: 
Tuesday, June 7, 2022

mCloud's AssetCare Digital Oilfield is the industry's only complete, end-to-end, digital upstream oil and gas solution.

Key Points: 
  • mCloud's AssetCare Digital Oilfield is the industry's only complete, end-to-end, digital upstream oil and gas solution.
  • AssetCare Digital Oilfield uses cloud-based AI to automate production management, continuously optimize wellsite performance, and drive predictive maintenance.
  • Integrated connected worker capabilities enable wellsite operators to eliminate unplanned downtime and correct methane emissions in hours instead of weeks or months.
  • On May 23, 2022, mCloud was featured in a 2022-2026 Global Augmented Reality Market report published by Research and Markets.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Investment in Okta, Inc. of Class Action Lawsuit and Upcoming Deadline – OKTA

Retrieved on: 
Sunday, June 5, 2022

NEW YORK, June 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Okta, Inc. (Okta or the Company) (NASDAQ: OKTA) and certain of its officers.

Key Points: 
  • NEW YORK, June 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Okta, Inc. (Okta or the Company) (NASDAQ: OKTA) and certain of its officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Okta provides identity solutions for enterprises, small and medium-sized businesses, universities, non-profits, and government agencies in the United States and internationally.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Oscar Health, Axsome, Humbl, and Okta and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, June 4, 2022

In March 2021, Oscar Health conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.

Key Points: 
  • In March 2021, Oscar Health conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • The Company also disclosed that its net loss for the quarter was $73.1 million, an increase of $32.1 million year-over-year.
  • Then, on November 10, 2021, Oscar Health disclosed that its third quarter 2021 MLR increased 920 basis points year-over-year, to 99.7%.
  • The Company also disclosed that its net loss for the quarter was $212.7 million, an increase of $133.6 million year-over-year.

Axsome Therapeutics, Inc. Investors: Contact the Portnoy Law Firm to Recover Losses

Retrieved on: 
Thursday, June 2, 2022

LOS ANGELES, June 02, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Axsome Therapeutics, Inc. (“Axsome” or the “Company”) (NASDAQ: AXSM) investors that a class action filed on behalf of investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Key Points: 
  • LOS ANGELES, June 02, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Axsome Therapeutics, Inc. (Axsome or the Company) (NASDAQ: AXSM) investors that a class action filed on behalf of investors are encouraged to contact attorney Lesley F. Portnoy ,by phone 844-767-8529 or email: [email protected] , to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors options for pursuing claims to recover their losses.
  • On this news, Axsome Inc.s share price plummeted thereby harming investors.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.